[1] Morita K, Taketomi A, Soejima Y, et al. De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation. Liver Transpl, 2009; 15, 1412−6. doi:  10.1002/lt.21894
[2] Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol, 2009; 10, 35−43. doi:  10.1016/S1470-2045(08)70284-5
[3] Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology, 2001; 33, 1394−403. doi:  10.1053/jhep.2001.24563
[4] Al-Joundi T, Gibson S, Brunt EM, et al. Delayed recurrence of hepatocellular carcinoma after liver transplantation: detection of origin by chromosomal analysis. Liver Transpl, 2000; 6, 374−5. doi:  10.1053/lv.2000.5202
[5] Altimari A, Gruppioni E, Fiorentino M, et al. Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation. Diagn Mol Pathol, 2005; 14, 34−8. doi:  10.1097/01.pas.0000143609.85487.36
[6] Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature, 2009; 458, 719−24. doi:  10.1038/nature07943
[7] Huang J, Deng Q, Wang Q, et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet, 2012; 44, 1117−21. doi:  10.1038/ng.2391
[8] Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics, 2010; 26, 589−95. doi:  10.1093/bioinformatics/btp698
[9] Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res, 2010; 38, e164. doi:  10.1093/nar/gkq603
[10] Li M, Zhao H, Zhang X, et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet, 2011; 43, 828−9. doi:  10.1038/ng.903